Clinically tested and proven In a recent 10-week clinical trial, participants experienced significant improvements in weight loss, digestion, energy, and appetite control.* 83% lost weight within 10 weeks 82% reduced food cravings within the first week 90% saw significant relief from bloating by week two 83% reported higher energy levels by week three *Clinical results are based on a self-reported survey conducted over 10 weeks with ColonBroom Premium
Our Ipamorelin Peptide is stored and handled according to industry guidelines to ensure stability
Assuming the remaining Phase 3 data continues to support both safety and efficacy, and the FDA review process moves forward without delays, industry projections currently point to a possible late 2026 to 2027 timeline
Being a newer treatment option, Tirzepatide is less likely to be covered by insurance plans
These components play crucial roles in breaking down fats, enhancing metabolism, and promoting overall vitality